Collplant Biotechnologies Ltd (CLGN) — Cash Flow-to-Debt Ratio
Collplant Biotechnologies Ltd (CLGN) has a Cash Flow-to-Debt Ratio of -0.60x as of September 2025, meaning its operating cash flow of $-2.88 Million could theoretically repay -1% of its total liabilities ($4.78 Million) in one year. See CLGN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Collplant Biotechnologies Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Collplant Biotechnologies Ltd across 13 annual periods. For the full cash flow conversion analysis, see Collplant Biotechnologies Ltd (CLGN) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Collplant Biotechnologies Ltd (2012–2024)
Year-by-year debt coverage analysis for Collplant Biotechnologies Ltd. Check CLGN cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.69x | $-14.09 Million | $5.25 Million | ▼ -462.7% |
| 2023 | -0.48x | $-2.76 Million | $5.79 Million | ▲ +80.9% |
| 2022 | -2.50x | $-13.70 Million | $5.49 Million | ▼ -709.2% |
| 2021 | 0.41x | $2.50 Million | $6.10 Million | ▲ +158.6% |
| 2020 | -0.70x | $-4.45 Million | $6.36 Million | ▲ +18.3% |
| 2019 | -0.86x | $-5.70 Million | $6.66 Million | ▼ -201.7% |
| 2018 | -0.28x | $-1.22 Million | $4.29 Million | ▲ +68.8% |
| 2017 | -0.91x | $-4.97 Million | $5.46 Million | ▲ +56.3% |
| 2016 | -2.08x | $-5.02 Million | $2.41 Million | ▲ +46.2% |
| 2015 | -3.87x | $-3.72 Million | $960.64K | ▲ +20.8% |
| 2014 | -4.89x | $-3.33 Million | $679.77K | ▼ -17.3% |
| 2013 | -4.17x | $-3.82 Million | $915.72K | ▲ +13.9% |
| 2012 | -4.84x | $-3.86 Million | $797.87K | — |